KIORA PHARMACEUTICALS INC Cash And Cash Equivalents At Carrying Value

Quick Answer

KIORA PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $8.70 million for the year ending 2025.

  • KIORA PHARMACEUTICALS INC showed an increase of +129.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), KIORA PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 1,635.2%.
  • Historical annual values: Fiscal year 2025: $8.70 million | Fiscal year 2024: $3.79 million | Fiscal year 2023: $2.45 million | Fiscal year 2022: $5.96 million | Fiscal year 2021: $7.85 million | Fiscal year 2020: $1.19 million | Fiscal year 2019: $3.78 million | Fiscal year 2018: $8.00 million | Fiscal year 2017: $7.81 million | Fiscal year 2016: $3.64 million | Fiscal year 2015: $8.39 million | Fiscal year 2014: $167.0 thousand | Fiscal year 2013: $501.2 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: